Soc. Generale Bonus Zert QIA 26.0.../ DE000SJ68445 /
| 1/24/2025 9:35:47 PM | Chg.-0.220 | Bid9:59:30 PM | Ask9:59:30 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 45.310EUR | -0.48% | 45.360 Bid Size: 500 |
45.650 Ask Size: 500 |
QIAGEN NV | - EUR | 9/26/2025 | Call |
GlobeNewswire
8/28/2024
QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in c...
GlobeNewswire
7/8/2024
QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
GlobeNewswire
6/27/2024
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis in...
GlobeNewswire
6/13/2024
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput N...
GlobeNewswire
6/12/2024
QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to su...
GlobeNewswire
6/11/2024
QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious dis...
GlobeNewswire
6/6/2024
QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition per...
GlobeNewswire
6/5/2024
QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire
6/3/2024
QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire
5/30/2024
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire
5/30/2024
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire
5/29/2024
QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire
5/14/2024
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire
5/13/2024
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire
5/7/2024
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire
5/7/2024
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
5/7/2024
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
5/2/2024
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire
4/29/2024
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance